Intracoronary delivery of bone-marrow-derived stem cells
Quang T Bui1, Zachary M Gertz, Robert L Wilensky
1Cardiovascular Division, Hospital of the University of Pennsylvania and Cardiovascular Institute, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Quang.T.Bui@Alum.Dartmouth.org
Insights
Stem cell therapy offers a promising approach to regenerate heart tissue damaged by ischemic heart disease. This review explores myocardial stem cell and progenitor cell therapy for treating infarcted myocardium.
Area of Science:
- Cardiology
- Regenerative Medicine
- Cell Therapy
Background:
- Ischemic heart disease (IHD) is a leading cause of death in Americans, causing heart failure and arrhythmias.
- Current therapies inadequately address the irreversible loss of cardiomyocytes following myocardial infarction.
- Cell transplantation therapy presents a promising strategy for improving cardiac function after heart damage.
Purpose of the Study:
- To review the therapeutic potential of myocardial stem and progenitor cell therapy.
- To focus on intracoronary delivery methods for treating infarcted myocardium.
Main Methods:
- Literature review of studies on stem cell and progenitor cell therapy for cardiac repair.
- Analysis of intracoronary delivery techniques and their efficacy in preclinical and clinical settings.
Main Results:
- Stem cell therapy demonstrates potential for regenerating damaged cardiomyocytes and improving cardiac function.
- Intracoronary delivery is a feasible route for myocardial cell transplantation.
- Further research is needed to optimize cell types, delivery, and long-term outcomes.
Conclusions:
- Myocardial stem and progenitor cell therapy, particularly via intracoronary delivery, holds significant promise for treating ischemic heart disease.
- This approach targets the underlying pathology of cardiomyocyte loss, offering a potential regenerative solution.
- Continued investigation is crucial for clinical translation and improving patient outcomes in managing infarcted myocardium.
Abstract:
Ischemic heart disease is the single greatest killer of Americans and its complications are a major cause of congestive heart failure and ventricular arrhythmias while signifiicantly contributing to increased health care costs and reduced patient quality of life. Advances in medical therapy, although signifiicant over the past decade, are still inadequate in regards to targeting the prime underlying pathology, the irreversible loss of damaged or dead cardiomyocytes. Research into the use of cell transplantation therapy to treat cardiac diseases, with the goal of improving cardiac function, shows promise. The aim of this review will be to discuss the potential therapeutic effects of myocardial stem cell and progenitor cell therapy delivered by an intracoronary route with special reference to treatment of infarcted myocardium.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...